Better For You Wellness (BFYW) 10-Q/A 17 Mar 23 2023 Q1 Quarterly report (amended) Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	May 31, 2022	Mar. 17, 2023
Document Information Line Items
Entity Registrant Name	BETTER FOR YOU WELLNESS, INC.
Document Type	10-Q/A
Current Fiscal Year End Date	--02-28
Entity Common Stock, Shares Outstanding		404,014,987
Amendment Flag	true
Amendment Description	Better For You Wellness, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-Q/A (this “Amendment No. 1”) to amend its Quarterly Report on Form 10-Q for the quarterly period ended May 31, 2022, filed with the Securities and Exchange Commission (the “SEC”) on July 15, 2022 (the “Original Form 10-Q”).Background of RestatementThis Amendment No. 1 is being filed for the sole purpose of restating certain of the financial statements included in the Original Form 10-Q (the “Restatement”) due to the Company discovering that it made the following errors in the Original Form 10-Q: (i) not translating correctly the foreign currency balance for a mark-to-market contract; and (ii) not including certain debt issuance costs in the computation of the effective interest rate for a loan note. In the Original Form 10-Q filed August 9, 2022, the negative net loss was reported as $1,373,066 for the three months ended May 31, 2022. The Amended and Restated negative net loss is reported as $ 891,872 a difference of $481,194 less in net loss for the three month period  ended May 31, 2022.In connection with the Restatement, management had concluded that the Company had a material weakness in its internal control over financial reporting as of May 31, 2022, as the Company’s internal control over financial reporting did not operate effectively, resulting in material errors in the financial statements included in the Original 10-Q. For a discussion of management’s considerations of the Company’s disclosure controls and procedures, internal control over financial reporting, and material weakness identified, refer to Controls and Procedures in Part I, Item 4.Internal Control ConsiderationsIn connection with the Restatement, management has concluded that the Company had a material weakness in its internal control over financial reporting as of May 31, 2022, as the Company’s review control over the accuracy of its financial statements did not operate effectively, resulting in material errors in the financial statements. For a discussion of management’s considerations of the Company’s disclosure controls and procedures, internal control over financial reporting, and material weakness identified, refer to Controls and Procedures in Part I, Item 4.Items Amended in this Amendment No. 1This Amendment No. 1 sets forth the Original Form 10-Q, as modified and superseded where necessary to reflect the Restatement and the related disclosure controls and procedures and internal control considerations. Accordingly, the following items included in the Original Form 10-Q have been amended: ●Part I, Item 1, Financial Statements     ●Part I, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations     ●Part I, Item 4, Controls and Procedures     ●Part II, Item 1A, Risk Factors Additionally, in accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended, the Company is including with this Amendment No. 1 currently dated certifications from its Chief Executive Officer, Chief Financial Officer, and President.Except as described above and in Note 9, Restatement, this Amendment No. 1 does not amend, update or change any other disclosures in the Original Form 10-Q. In addition, the information contained in this Amendment No. 1 does not reflect events occurring after the Original Form 10-Q and does not modify or update the disclosures therein, except to reflect the effects of the Restatement.
Entity Central Index Key	0001852707
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	May 31, 2022
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-56262
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	87-2903933
Entity Address, Address Line One	1349 East Broad Street
Entity Address, City or Town	Columbus
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	43205
City Area Code	(614)
Local Phone Number	368-9898
Entity Interactive Data Current	Yes

Condensed Consolidated Balance

Condensed Consolidated Balance Sheet (unaudited) - USD ($)	May 31, 2022	Feb. 28, 2022
CURRENT ASSETS
Cash and cash equivalents	$ 3,309	$ 9,642
Inventory	7,037
Prepaids and other assets	78,072
Total Current assets	88,418	9,642
Equipment, net	2,129
Goodwill	583,586
TOTAL ASSETS	674,133	9,642
Current Liabilities
Accounts Payable	161,815	375,408
Deferred Compensation	100,160
Clearbanc Debit Card	2,288
Related Party Notes Payable	35,000
Total Current Liabilities	299,263	375,408
Notes Payable - PayPal Capital	2,335
Notes Payable Shopify Capital	483
Convertible notes payable, net accumulated interest	254,369
TOTAL LIABILITIES	556,449	375,408
Stockholders’ Equity (Deficit)
Preferred stock ($.0001 par value, 200,000,000 shares authorized; 700,000 issued and outstanding as of May 31, 2022 and February 28, 2022)	70	70
Common stock ($.0001 par value, 500,000,000 shares authorized, 380,108,169 and 370,747,042 issued and outstanding as of May 31, 2022 and February 28, 2022, respectively)	38,012	37,075
Additional paid-in capital	2,609,749	1,485,364
Shares cancellable		(250,000)
Accumulated deficit	(2,530,147)	(1,638,275)
Total Stockholders’ Equity (Deficit)	117,684	(365,766)
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY (DEFICIT)	$ 674,133	$ 9,642

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheet (unaudited) (Parentheticals) - $ / shares	May 31, 2022	Feb. 28, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	200,000,000	200,000,000
Preferred stock, shares issued	700,000	700,000
Preferred stock, shares outstanding	700,000	700,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	380,108,169	370,747,042
Common stock, shares outstanding	380,108,169	370,747,042

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	May 31, 2022	May 31, 2021
Revenue
Merchandise Sales	$ 306
Cost of Goods Sold	6,069
Gross Profit	(5,763)
Operating Expenses:
Share-based expense	684,050
Selling, General and Administrative	196,995	$ 72,051
Total operating expenses	881,045	72,051
Operating Income/(Loss)	(886,808)	(72,051)
Other Income/(Expense)
Other income
Interest expense	(5,063)
Other expense
Total other expense	(5,063)
Net income/(loss)	$ (891,872)	$ (72,051)
Basic net loss per common share (in Dollars per share)	$ 0	$ 0
Weighted average number of common shares outstanding - Basic (in Shares)	363,657,794	140,868,130

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended
	May 31, 2022	May 31, 2021
Income Statement [Abstract]
Diluted net loss per common share	$ 0	$ 0
Weighted average number of common shares outstanding - Diluted	363,657,794	195,652,174

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit) - USD ($)	Common Common	Series A Series A	Common	Series A	Additional Paid-in-Capital	Shares Cancellable	Noncontrolling Interest	Accumulated Deficit	Total
Balances at Feb. 28, 2021				$ 1,185	$ (4,935)		$ (3,750)
Balances (in Shares) at Feb. 28, 2021
Common shares issued after reorganization				$ (36,000)					$ 359,996,332
Common shares issued after reorganization (in Shares)			36,000
Series A preferred shares issued after reorganization			$ 700,000	$ 69,930			70,000
Series A preferred shares issued after reorganization (in Shares)				700
Expenses paid on behalf of the Company and contributed to capital				$ 3,951			3,951
Net loss					(72,051)		(72,051)		(72,051)
Balances at May. 31, 2021			$ 700,000	$ 39,067	(76,986)		(1,850)		359,996,332
Balances (in Shares) at May. 31, 2021			36,000	700
Balances at Feb. 28, 2022	$ 37,075	$ 70			1,485,364	$ (250,000)	(1,638,275)	$ (365,766)	(365,766)
Balances (in Shares) at Feb. 28, 2022	370,747,042	700,000
Common shares cancelled and returned to the Company	$ (705)				(249,295)	250,000
Common shares cancelled and returned to the Company (in Shares)	(7,048,873)
Common shares issued for shares payable	$ 33				(33)
Common shares issued for shares payable (in Shares)	325,000
Common shares issued for services to Company	$ 509				272,226			272,735
Common shares issued for services to Company (in Shares)	5,085,000
Common shares issued for purchase of subsidiary	$ 1,100				548,900			550,000
Common shares issued for purchase of subsidiary (in Shares)	11,000,000
Stock option expense					411,315			411,315
Warrants Issued					78,072			78,072
Warrants Issued					13,514			13,514
Debt Forgiveness					49,686			49,686
Net loss							(891,872)	(891,872)	(891,872)
Balances at May. 31, 2022	$ 38,012	$ 70			$ 2,609,749		$ (2,530,147)	$ 117,684	$ 117,684
Balances (in Shares) at May. 31, 2022	380,108,169	700,000

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($)	3 Months Ended
	May 31, 2022	May 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (891,872)	$ (72,051)
Adjustment to reconcile net loss to net cash used in operating activities:
Share based expenses	684,050	70,000
Amortized debt discount and debt issuance costs	12,139
Depreciation	194
Changes in current assets and liabilities:
Inventory	6,060
Accounts Payable	(213,593)	(1,900)
Accrued Interest	5,063
Deferred Compensation	100,160
Other liabilities	(6,403)
Net cash used in Operating Activities	(304,202)	(3,951)
CASH FLOWS FROM INVESTING ACTIVITIES:
Fixed Asset	(2,323)
Net cash used in Investing Activities	(2,323)
CASH FLOWS FROM FINANCING ACTIVITIES
Payment of debt issuance Cost	(28,320)
Proceeds from Convertible loan, net of original issue discount	279,000
Proceed from related party note payable
Notes Payable – LT	(174)
Noncontrolling interest
Expenses contributed to capital	49,686	3,951
Net cash provided by financing activities	300,192	3,951
Net change in cash	(6,333)
Beginning cash balance	9,642
Ending cash balance	3,309
NON-CASH FINANCING TRANSACTIONS:
Discount on notes payable for warrants	13,514
Warrants issued and extended for common stock issuance costs	$ 78,072

Organization and Description of

Organization and Description of Business	3 Months Ended
	May 31, 2022
Organization and Description of Business [Abstract]
Organization and Description of Business	Note 1 - Organization and Description of Business Better For You Wellness, Inc. (“we,” “us,” “our”, the “Company” or the “Registrant”) was originally incorporated with the name Fast Track Solutions, Inc. in the State of Nevada on December 1, 2020. On April 26, 2021, the Company entered into an “Agreement and Plan of Merger”, whereas it agreed to, and subsequently participated in, a Nevada holding company reorganization pursuant to NRS 92A.180, NRS 92A.200, NRS 92A.230 and NRS 92A.250 (“Reorganization”). The constituent corporations in the Reorganization were Sauer Energy, Inc. (“SENY” or “Predecessor”), Fast Track Solutions, Inc. (“Successor”), and Fast Track Merger Sub, Inc. (“Merger Sub”). Our former director, Jeffrey DeNunzio, was the sole director/officer of each constituent corporation in the Reorganization. Fast Track Solutions, Inc. issued 1,000 common shares of its common stock to Predecessor and Merger Sub issued 1,000 shares of its common stock to Fast Track Solutions, Inc. immediately prior to the Reorganization. As such, immediately prior to the merger, Fast Track Solutions, Inc. became a wholly owned direct subsidiary of Sauer Energy, Inc. and Merger Sub became a wholly owned and direct subsidiary of Fast Track Solutions, Inc. Pursuant to the above, on April 26, 2021, Sauer Energy, Inc. filed Articles of Merger with the Nevada Secretary of State. The merger became effective on May 5, 2021, at 4:00 PM EST (“Effective Time”). At the Effective Time, Predecessor was merged with and into Merger Sub (the “Merger), and Predecessor became the surviving corporation. Each share of Predecessor common stock issued and outstanding immediately prior to the Effective Time was converted into one validly issued, fully paid and non-assessable share of Fast Track Solutions, Inc.’s (“Successors”) common stock. Fast Track Solutions, Inc., as successor issuer to Sauer Energy, Inc., continued to trade in the OTC MarketPlace under the previous ticker symbol “SENY” until the new ticker symbol “FTRK” for the Company was released into the OTC MarketPlace on May 6, 2021. The Company was given a new CUSIP Number by CUSIP Global Services for its common stock of 31188W108. The Company believes that the Reorganization, deemed effective on May 5, 2021, was not a transaction of the type described in subparagraph (a) of Rule 145 under the Securities Act of 1933 and the consummation of the Reorganization will not be deemed to involve an “offer”, “offer to sell”, “offer for sale” or “sale” within the meaning of Section 2(3) of the Securities Act of 1933. The Reorganization was consummated without the vote or consent of the Company’s stockholders. In addition, the provisions of NRS 92A.180 did not provide a stockholder of the Company with appraisal rights in connection with the Reorganization. The Company believes that in the absence of any right of any of the Company’s stockholders to vote with respect to the Reorganization or to insist that their shares be purchased for fair value, the Reorganization could not be deemed to involve an “offer” “offer to sell”; or “sale” within the meaning of Section 2(3) of the Securities Act of 1933.” On May 5, 2021, after the completion of the Holding Company Reorganization, we canceled all of the stock we held in Sauer Energy, Inc., resulting in Sauer Energy, Inc. as a stand-alone company. Pursuant to the holding company merger agreement and effects of merger, all of the assets and liabilities, if any, remain with Sauer Energy, Inc. after the Reorganization. Jeffrey DeNunzio, the Director of Sauer Energy, Inc., did not discover any assets of Sauer Energy, Inc. from the time he was appointed Director until the completion of the Reorganization and subsequent separation of Sauer Energy, Inc. as a stand-alone company. Given that the former business plan and objectives of Sauer Energy, Inc. and the business plan and objectives of Fast Track Solutions, Inc. substantially differed from one another, we conducted the corporate separation with Sauer Energy, Inc. immediately after the effective time of the Reorganization in order to avoid any shareholder confusion. The former business plan of Sauer Energy, Inc. (the development and marketing of wind powered electric generators) under the leadership of its former directors, did not, in any way, represent the blank check business plan of Fast Track Solutions, Inc. at that time, and thus it is the belief of the Company that the corporate separation ameliorated shareholder confusion about our identity and/or corporate objectives. It is our belief that Sauer Energy was a shell company at the time of the Reorganization. The corporate actions taken by the Company, including, but not limited to, the corporate structuring of the transactions, was deemed, in the discretion of our sole director, to be for the benefit of the corporation and its shareholders. Former shareholders of Sauer Energy, Inc. were then the shareholders of Fast Track Solutions, Inc. and had the opportunity to benefit from a business combination with another company. The Company intended to serve as a vehicle to affect an asset acquisition, merger, exchange of capital stock or other business combination with a domestic or foreign business at that time After the reorganization and through July 18, 2021, CRS Consulting, LLC, a Wyoming LLC owned and controlled by Jeffrey DeNunzio, Thomas DeNunzio and Paul Moody, was our controlling shareholder, owning 700,000 shares of Series A Preferred Stock and 250,000,000 shares of Restricted Common Stock. On July 19, 2021, Better For You Wellness, Inc., FKA “Fast Track Solutions, Inc.”, a Nevada Corporation (the “Company”), entered into a Share Purchase Agreement (the “Agreement”) by and among CRS Consulting, LLC, a Wyoming Limited Liability Company (“CRS”), Green Ohio Ventures, LLC, an Ohio Limited Liability Company (“GOHV”), Ian James, and Stephen Letourneau, pursuant to which, on July 30, 2021 (“Closing Date”), CRS sold 700,000 shares of the Company’s Series A Preferred Stock and 250,000,000 shares of Common Stock, representing approximately 89.62% voting control of the Company; 350,000 shares of Series A Preferred Stock were transferred to Ian James, 350,000 shares of Series A Preferred Stock were transferred to Stephen Letourneau, and 250,000,000 shares of Common Stock were transferred to GOHV. The aforementioned purchasers, collectively, paid consideration of three hundred thirty-five thousand dollars ($335,000) (the “Purchase Price”). The consummation of the transactions contemplated by the Agreement resulted in a change in control of the Company, with GOHV, Ian James, and Stephen Letourneau, becoming the Company’s largest controlling stockholders having approximately 89.62% combined voting control over the Company. Pursuant to the Agreement, on July 30, 2021, Mr. Jeffrey DeNunzio resigned as the Company’s Chief Executive Officer, Chief Financial Officer, President, Secretary, Treasurer, and Director. On July 30, 2021, Mr. Ian James was appointed as the Company’s Chief Executive Officer, Chief Financial Officer, President, Secretary, Treasurer, and Chairman of the Board of Directors and Mr. Stephen Letourneau was appointed as a Director. On August 19, 2021, the Company filed an 8-K with the SEC to disclose an amendment to the Company’s Articles of Incorporation that the Company filed on August 18, 2021, with the Nevada Secretary of State to change its name to Better For You Wellness, Inc. Within the aforementioned 8-K, the Company disclosed that, at the time, it was pending a FINRA corporate action to affect the name change on the OTC to Better For You Wellness, Inc., and also a ticker symbol change. FINRA announced, on their September 29, 2021 daily list, that the market effective date of our name change, and ticker symbol change, will be September 30, 2021. On September 30, 2021, we will begin trading under the symbol BFYW. The new CUSIP number associated with our common stock, as of the market effective date of September 30, 2021, is 08771B105. On August 24, 2021, Green Ohio Ventures, LLC transferred 17,963,817 shares of restricted Common Stock of Better for You Wellness, Inc. to MRKTS Group Inc. for consulting services provided. This transaction did not result in MRKTS Group Inc. owning 5% or more of any class of securities of the issuer. From August 24, 2021 to August 25, 2021, Green Ohio Ventures, LLC distributed, at no cost and in various quantities, a total of 24,137,499 shares of restricted Common Stock of Better for You Wellness, Inc. to 18 of its 20 members. No shares were distributed from GOHV to Ian James and Stephen Letourneau. The aforementioned transaction(s) did not result in any individual shareholder owning 5% or more of any class of securities of the issuer. The aforementioned transaction was carried out as it was deemed by GOHV to be in the best interests of its members. On August 27, 2021, Montel Williams, Leslie G. Bumgarner, Joseph J. Watson, David H. Deming, and Dr. Nicola R. Finley, MD, were each appointed by our Board of Directors to serve as Independent Directors of the Company. On September 1, 2021, we entered into Independent Director Agreements with each of Montel Williams, Leslie G. Bumgarner, Joseph J. Watson, David H. Deming, and Dr. Nicola R. Finley, MD, pursuant to which each director will serve two year terms, with the option to renew terms upon completion, and receive cash compensation in the amount of $1,000 per annum, paid in equal $250 distributions quarterly, and 200,000 shares of common stock, issued quarterly in 25,000 share distributions, and a non-qualified stock option to purchase up to 4,000,000 shares of the Company’s common stock at an exercise price of $0.25 per share. The Directors were officially seated September 12, 2021, after notification to shareholders. On December 14, 2021, the Company’s Board of Directors unanimously approved the appointment of Christina Jefferson to the Board as an Independent Director, effective January 1, 2022. Christina Jefferson replaced Leslie Bumgarner whose resignation, as previously announced, became effective December 31, 2021. On February 3. 2022, the Company was approved by OTC Markets to up-list its common stock from the OTC Pink Sheets to the OTCQB® Venture Market (the “OTCQB”). The Company began trading of its common shares on the OTCQB as of the market open on February 3, 2022, under its same symbol, “BFYW.” On February 5, 2022, the Company’s Board of Directors unanimously approved the establishment of a Strategic Advisory Committee. The Board appointed six initial members by unanimous consent including David King, Laurie Racine, Zhiping Zhang, Melisse Gelula, Christopher Brown, and Kate Hendrickson. Also on February 5, 2022, by unanimous vote of the Company’s Board of Directors’ five non-executive Independent Directors, David Deming was appointed Chairperson of the Company’s Audit Committee, which follows the Board’s October 1, 2021, unanimous consent to establish the Audit Committee. The Audit Committee currently consists of three non-executive Independent Directors, including Montel Williams, Joseph Watson, and David Deming. Also, by unanimous vote of the Board’s five non-executive Independent Directors, Christina Jefferson was appointed to the Company’s Compensation Committee, filling the vacancy left by former Director Leslie Bumgarner. This action follows the Board’s October 1, 2021, unanimous consent to establish the Compensation Committee. The Compensation Committee currently consists of Independent Directors, Christina Jefferson, Montel Williams, and Joseph Watson. Additionally, the Board’s five non-executive Independent Directors unanimously appointed Joseph Watson as Chairperson of the Compensation Committee. The Company’s current business plan is to explore and evaluate various opportunities in the plant-based food and beverage and consumer packaged goods sectors, including but not limited to, mergers, acquisitions, or business combination transactions, after which the Company would cease to be a “shell” or “blank check” company. The Company’s principal business objective for the next 12 months and beyond will be to achieve long-term growth potential through a combination with a business rather than immediate, short-term earnings. On November 15, 2021, the Company’s wholly owned subsidiary, Glow Market, LLC was formed in the State of Ohio. Subsequently, Glow Market, LLC launched its first brand, Better Suds, an online retailer of specialty all-natural, cruelty-free, gluten-free and chemical-free soaps. Better Suds commenced operations in December 2021. On April 29, 2022 the Company entered into a Membership Interest Purchase Agreement (the “MIPA”) with Amanda Cayemitte and Yapo M’be (referred to together as the “Sellers”) to acquire the right, title and interest in, including all of the outstanding membership interests (referred to together as the “MM Interests”) of Mango Moi, LLC (“Mango Moi”). Mango Moi is a hair and skincare business located in Chicago, Illinois. Pursuant to the MIPA, in exchange for the MM Interests, the Company agreed to pay the Sellers a purchase price consisting of shares of the Company’s common stock, par value $0.0001 per share which consists of 11,000,000 shares of common stock (the “Company Common Stock”), with a fair market value of approximately $550,000, with 5,720,000 shares of Company Common Stock issued to Amanda Cayemitte and 5,280,000 shares of Company Common Stock issued to Yapo M’be (referred to together herein as the “Purchase Price”). Additionally, pursuant to the terms of the MIPA, the Company agreed to enter into an Employment Agreement with Mango Moi founder Amanda Cayemitte (the “Employment Agreement”), and a Consulting Agreement with Yapo M’be (the “Consulting Agreement”), respectively, as disclosed by the Company on its Current Report on Form 8-K filed with the SEC on May 2, 2022. The MIPA closed (the “Closing”) on May 26, 2022, on which date the Company paid the Sellers the Purchase Price by issuing the Company Common Stock to the Sellers and the Sellers transferred the MM Interests to the Company, and on which date Mango Moi became a wholly owned subsidiary of the Company. At the Closing the Company entered into the Employment Agreement with Amanda Cayemitte and the Consulting Agreement with Yapo M’be. The Company intends to optimize Mango Moi’s product formulae and packaging, as well as secure new manufacturing relationships to scale production capacity. Additionally, the Company plans to expand Mango Moi’s product offerings to include additional products and product bundles. Furthermore, the Company intends to grow sales through direct-to-consumer marketing efforts, subscription box sales, and pursuing wholesale sales relationships. The Company’s main office is located at 1349 East Broad Street, Columbus OH 43205. The Company has elected February 28th as its year end.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	May 31, 2022
Organization and Description of Business [Abstract]
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Principles of Consolidation The accompanying interim unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”), including the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in the Company’s annual consolidated financial statements on Form 10-K have been condensed or omitted. The condensed consolidated balance sheet as of February 28, 2022 has been derived from the audited consolidated financial statements as of that date, but does not include all disclosures required for audited annual financial statements. For further information, please refer to and read these interim condensed Consolidated Financial Statements in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 28, 2022 filed with the SEC. Significant Accounting Policies and Use of Estimates: There were no material changes in the Company’s significant accounting policies for the three months ended May 31, 2022 as compared to the year ended February 28, 2022. See Note 2 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended February 28, 2022, as filed with the SEC, for additional information regarding the Company’s significant accounting policies and use of estimates. The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ significantly from those estimates. The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates the valuation allowance associated with the Company’s deferred tax assets. Revenue Recognition The Company has prepared its unaudited condensed consolidated financial statements in accordance with GAAP. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. The Company adopted ASC 606 - Revenue from contracts with Customers: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. Revenue for products is recognized when the products are delivered to the customer, and the customer completes the product inspection. Cash receipts for undelivered products are recorded as deferred revenues. As of May 31, 2022 and February 28, 2021, the Company had no deferred revenues. Basis of Presentation This summary of significant accounting policies is presented to assist in understanding the Company’s unaudited condensed consolidated financial statements. These accounting policies conform to accounting principles, generally accepted in the United States of America, and have been consistently applied in the preparation of the financial statements. Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents at May 31, 2022 and February 28, 2022 was $3,309 and $9,642, respectively. Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Depreciation is provided using the straight-line method over the estimated useful lives of the related assets (primarily three to five years). Income Taxes The Company accounts for income taxes under ASC 740, “ Income Taxes Basic Earnings (Loss) Per Share The Company computes basic and diluted earnings (loss) per share in accordance with ASC Topic 260, Earnings per Share The Company does not have any potentially dilutive instruments as of May 31, 2022 and 2021. Thus, anti-dilution issues are not applicable. Fair Value of Financial Instruments The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. ASC 820, Fair Value Measurements and Disclosures - Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. - Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. - Level 3 - Inputs that are both significant to the fair value measurement and unobservable. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of May 31, 2022 and February 28, 2022. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accrued expenses. Related Parties The Company follows ASC 850, Related Party Disclosures, Share-Based Compensation ASC 718, “ Compensation - Stock Compensation The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “ Equity – Based Payments to Non-Employees.” Except as specified for the Independent Directors’ compensation, the Company had no stock-based compensation plans as of May 31, 2022 and February 28, 2022. Recently Issued Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13 “Credit Losses - Measurement of Credit Losses on Financial Instruments.” ASU No. 2016-13 significantly changes how entities will measure credit losses for most financial assets, including accounts and notes receivables, by replacing today’s “incurred loss” approach with an “expected loss” model under which allowances will be recognized based on expected rather than incurred losses. ASU No. 2016-13 will become effective for us in the first quarter of 2023. We are evaluating the impact that the adoption of this update will have on our financial statements; however, it is not expected to be material. Reclassification of Prior Year Presentation Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

Going Concern

Going Concern	3 Months Ended
	May 31, 2022
Going Concern [Abstract]
Going Concern	Note 3 - Going Concern The Company’s financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company demonstrates adverse conditions that raise substantial doubt about the Company’s ability to continue as a going concern for one year following the issuance of these financial statements. These adverse conditions are negative financial trends, specifically operating loss, working capital deficiency, and other adverse key financial ratios. The Company has not established any source of revenue to cover its operating costs. Management plans to fund operating expenses with related party contributions to capital. There is no assurance that management’s plan will be successful. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event that the Company cannot continue as a going concern.

Business Combinations

Business Combinations	3 Months Ended
	May 31, 2022
Business Combinations [Abstract]
Business Combinations	Note 4 - Business Combinations On April 29, 2022, we entered into an asset purchase agreement to acquire substantially all of the assets of Mango Moi. The acquisition was accounted for in accordance with GAAP and was made to expand our market share in the personal care category and due to synergies of product lines and services between the Companies. The acquisition closed May 26, 2022. The purchase price has been preliminarily allocated to assets acquired and liabilities assumed based on the estimated fair value of such assets and liabilities at the date of acquisitions as follows: Assets acquired: Cash $ 913 Inventory 12,995 Total Assets Acquired 13,908 Liabilities assumed: Clearbanc Debit Card 2,365 Notes Payable - PayPal Capital 2,454 Notes Payable Shopify Capital 537 Sales Tax Payable 138 Total Liabilities Assumed 5,494 Total identifiable net assets 8,414 Purchase price 592,000 Goodwill - Excess of purchase price over fair value of net assets acquired on acquisition date $ 583,586 The purchase price of $592,000 was paid in stock and discharge of liability in cash as a combination. Goodwill in the amount of $583,586 was recognized in the acquisition of Mango Moi LLC and is attributable to the cash flows of the business derived from our potential to outperform the market due to its existing relationship and other synergies created within the Company. As the Company finalizes the fair value of assets acquired and liabilities assumed, additional purchase price adjustments may be recorded. The finalization of the purchase accounting assessment may result in changes in the valuation of assets acquired and liabilities assumed and may have an impact on the Company’s results of operations and financial position. The following unaudited pro forma information presents a summary of the condensed consolidated results of operations for the Company as if the acquisition of Mango Moi had occurred on March 1, 2021. For the Three months ended (unaudited) (unaudited) May 31, May 31, Total revenues $ 6,974 $ 19,455 Net (loss) income $ (891,872 ) $ (90,902 ) Loss per share $ - $ - The unaudited pro forma consolidated results are based on our historical financial statements and those of Mango Moi and do not necessarily indicate the results of operations that would have resulted had the acquisition actually been completed at the beginning of the applicable period presented. The pro forma financial information assumes that the companies were combined as of March 1, 2021. The following tables present the amounts of revenue and earnings of Mango Moi since the acquisition date included in the condensed consolidated income statement for the reporting period. For the For the 2022 2021 Mango Moi: Total revenues $ 6,974 $ 19,455 Net income $ (8,281 ) $ (9,425 )

Income Taxes

Income Taxes	3 Months Ended
	May 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Note 5 - Income Taxes The Company accounts for income taxes under ASC 740, “ Income Taxes

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	May 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 6 - Commitments and Contingencies The Company follows ASC 450-20, Los Contingencies, On September 17, 2021, our Board of Directors unanimously approved to enter into and consummate a “Term Sheet” with Williamsburg Venture Holdings LLC, a Nevada limited liability company (“WVH”). WVH is a multi-strategy, private investment fund located in New York. The Term Sheet is a private placement with registration rights, providing WVH the ability to purchase up to $30,500,000 of our Common Stock. The term of the Term Sheet is for 36 months. Following the execution of the term sheet, the Company is to pay WVH $15,000 to cover associated expenses relating to, amongst other things, preparation of future securities agreements relating to the Term Sheet. Upon entering into definitive agreements with WVH for the purchase and sale of equity, WVH is to immediately purchase $250,000 of the Company’s restricted common stock from the Company at a 15% discount to the last closing price of our Common Stock as reported by the OTC Markets Group. Any future proceeds from the sale of shares, pursuant to the aforementioned term sheet, are to go towards the Company to be used for working capital. Pursuant to the Term Sheet, WVH may not acquire, at any point, more than 4.99% of our outstanding shares of common stock. On September 17, 2021, our Board of Directors unanimously approved to enter into and consummate an agreement with SRAX, Inc., a Delaware Company (“SRAX”). Pursuant to the agreement with SRAX, the Company will be granted access to a platform developed by SRAX, known as the “Sequire Platform” which, amongst other things, will allow the Company to access trading data. According to SRAX, the platform is an investor intelligence and communications management platform that allows users to “unlock stock buyers’ behaviors and trends for issuers of publicly traded companies”. In exchange for twelve months of access to the Sequire Platform, we paid SRAX $20,000. Additional fees may be incurred as a result of this agreement, but we cannot accurately determine what they may be, although we believe any such fees would be nominal. Also on September 17, 2021, our Board of Directors unanimously agreed to approve to enter into and consummate another agreement with SRAX, whereas SRAX will provide advertising and marketing services to the Company on a case-by-case basis, as may be requested by the Company. On May 26, 2022 the Company acquired Mango Moi, LLC as a wholly-owned subsidiary (See Note 1). As part of the purchase agreement, the Company entered into an employment agreement and a consulting agreement as follows: Employment Agreement Pursuant to the Employment Agreement, which is to be effective as of 45 days from the signing of the MIPA, the Company agreed to employ Amanda Cayemitte as the Chief Visionary Officer of Mango Moi to provide duties including normalizing the Company’s strategic-planning processes, forging new working relationships and synergies across the organization, and establishing greater transparency and accountability for those people carrying out the Company’s strategy. As compensation under the Employment Agreement, the Company agreed to pay Amanda Cayemitte an annual salary of $65,000 payable semi-monthly on the first day and the fifteenth day of the month and subject to applicable federal, state, and local withholding. The Employment Agreement can be terminated any time by either party by giving 30 days written notice to the other party. If the Employment Agreement is terminated, Amanda Cayemitte will be entitled to receive compensation for: ● one month upon completion of one full calendar year of employment with the Company; ● two months upon completion of two full calendar years of employment with the Company, and ● three months upon competition of two full calendar years of employment with the Company. However, if Amanda Cayemitte breaches any terms of the Employment Agreement, the Company may terminate the Employment Agreement without any notice and with compensation being paid to Amanda Cayemitte only through the date of such termination. Consulting Agreement Pursuant to the Consulting Agreement, the Company engaged Yapo M’be as a consultant to provide manufacturing services for Mango Moi, to begin on May 2, 2022. As compensation under the Consulting Agreement, the Company agreed to pay Yapo M’be at the rate of $30.00 per hour, not to exceed $1,500 per month. The Consulting Agreement can be terminated by either party upon the failure of the other to perform under the Consulting Agreement by giving ten days written notice to the non-performing party. The Consulting Agreement can also be terminated by the Company by giving ten days written notice to Yapo M’be in the event that there is a reduction of the program budget.

Convertible Note Payable

Convertible Note Payable	3 Months Ended
	May 31, 2022
Convertible Note Payable Disclosure [Abstract]
Convertible Note Payable	Note 7 - Convertible Note Payable On April 12, 2022, the Company entered into a Securities Purchase Agreement (the “Purchase Agreements”) with Mast Hill Fund, L.P., a Delaware limited partnership (“Mast Hill”), respectively, pursuant to which Mast Hill purchased a promissory note, with a principal amount of $310,000 for a purchase price of $279,000 (the “Note”). The closing of the Purchase Agreements occurred on April 12, 2022. The Note bears an original issue discount of $31,000, each bear interest of 12% per year and mature on April 12, 2023 (the “Maturity Date”). The Note is convertible into shares of the Company’s common stock at conversion price of $0.037 per share, subject to adjustment as provided therein. The Company has the right to prepay the Note in full, including accrued but unpaid interest, without prepayment penalty provided an event of default, as defined therein, has not occurred. In the seven (7) trading days prior to any prepayment Mast Hill shall have the right to convert their Note into Common Stock of the Company in accordance with the terms of such Note. The Note contains events of defaults and certain negative covenants that are typical in the types of transactions contemplated by the Purchase Agreements. Pursuant to the Purchase Agreements, the Company issued to Mast Hill 4,960,000 commitment shares of the Company’s common stock (the “Commitment Shares”) as a condition to closing.

Stock Purchase Warrant Liabilit

Stock Purchase Warrant Liability	3 Months Ended
	May 31, 2022
Stock Purchase Warrant Liability [Abstract]
Stock Purchase Warrant Liability	Note 8 - Stock Purchase Warrant Liability On April 18, 2022, Better For You Wellness, Inc., a Nevada corporation (the “Company”), entered into a Standby Equity Commitment Agreement, dated April 11, 2022 (the “SECA”) with MacRab LLC, a Florida limited liability company (the “Investor”). The SECA provides the Company with an option to sell up to $5,000,000 worth of the Company’s common stock, par value $0.0001 (the “Common Stock”), to the Investor, in increments, over the period ending twenty-four (24) months after the date the Registration Statement (as defined below) is deemed effective by the U.S. Securities and Exchange Commission, pursuant to the terms and conditions contained in the SECA. The purchase price per share, for each respective put under the SECA, is equal to 90% of the average of the two (2) lowest volume weighted average prices of the Common Stock during the six (6) trading days following the clearing date associated with the respective put under the SECA. Additionally, we issued a common stock purchase warrant for the purchase of 1,785,714 shares of our common stock (the “Warrant”) to Investor as a commitment fee in connection with the execution of the SECA. The Company fair valued the shares purchase warrant on the closing date at $36,366 using a Black-Scholes put option pricing model.

Shareholder Equity

Shareholder Equity	3 Months Ended
	May 31, 2022
Shareholder Equity [Abstract]
Shareholder Equity	Note 9 - Shareholder Equity Preferred Stock The authorized preferred stock of the Company consists of 200,000,000 shares with a par value of $0.0001. There were 700,000 shares issued and outstanding as of May 31, 2022 and February 28, 2022. During the three months ended May 31, 2021, 700,000 shares of Series A Preferred Stock were issued to CRS Consulting, LLC (“CRS”), a Wyoming LLC owned and controlled by Jeffrey DeNunzio, Thomas DeNunzio and Paul Moody. CRS is our controlling shareholder, owning 700,000 shares of Series A Preferred Stock and 250,000,000 shares of Restricted Common Stock. Series A Preferred Stock has no conversion rights to any other class, and every vote of Series A Preferred Stock has voting rights equal to 1,000 votes of Common Stock. On July 19, 2021, these shares were purchased. As of November 30, 2021, our CEO, Ian James, and Director, Stephen Letourneau, each hold 350,000 shares of Series A Preferred Stock (See Note 1). Common Stock The authorized common stock of the Company consists of 500,000,000 shares with a par value of $0.0001. There were 380,108,169 and 370,747,042 shares of common stock issued and outstanding as of May 31, 2022 and February 28, 2022, respectively. At the time of reorganization, former shareholders of Sauer Energy, Inc. became shareholders of Fast Track Solutions, Inc., representing 359,996,332 of the common shares outstanding. On July 19, 2021, 250,000,000 shares of restricted Common Stock were purchased by Ohio Green Ventures, LLC from CRS Consulting, LLC, a Wyoming LLC owned and controlled by Jeffrey DeNunzio, Thomas DeNunzio and Paul Moody (See Note 1). On August 24, 2021, Green Ohio Ventures, LLC transferred 17,963,817 shares of restricted Common Stock of Better for You Wellness, Inc. to MRKTS Group Inc. for consulting services provided. From August 24, 2021 to August 25, 2021, Green Ohio Ventures, LLC distributed, at no cost and in various quantities, a total of 24,137,499 shares of restricted Common Stock of Better for You Wellness, Inc. to 18 of its 20 members. No shares were distributed from GOHV to Ian James and Stephen Letourneau (See Note 1). On August 24, 2021, 50,000 shares of Restricted Common Stock were issued to CRS as compensation for consulting services to the Company. The shares were valued at the closing share price on that date, as listed on the OTC Markets, which totalled $7,000. On October 11, 2021, 2,602,740 shares of Restricted Common Stock were issued to SRAX, Inc as compensation for marketing services to the Company. The shares were valued at the closing share price on that date, as listed on the OTC Markets, which totalled $468,493. On October 11, 2021, 250,000 shares of Restricted Common Stock were issued to CRS as compensation for consulting services to the Company. The shares were valued at the closing share price on that date, as listed on the OTC Markets, which totalled $45,000. On November 17, 2021, 125,000 shares of Restricted Common Stock were issued to five Directors serving on the Company’s Board of Directors as compensation for services to the Company. The shares were valued at the closing share price on that date, as listed on the OTC Markets, which totalled $18,750. On January 3, 2022, 125,000 shares of Restricted Common Stock were issued to five Directors serving on the Company’s Board of Directors as compensation for services to the Company. The shares were valued at the closing share price on that date, as listed on the OTC Markets, which totalled $15,000. On April 12, 2022, the Company entered into a Securities Purchase Agreement with Mast Hill Fund, L.P., in which Mast Hill purchased a promissory note, with a principal amount of $310,000 for a purchase price of $279,000 (the “Note”). The closing of the Purchase Agreements occurred on April 12, 2022. The Note bears an original issue discount of $31,000, each bear interest of 12% per year and mature on April 12, 2023 (the “Maturity Date”). The Note is convertible into shares of the Company’s common stock at conversion price of $0.037 per share, subject to adjustment as provided therein. The Company has the right to prepay the Note in full, including accrued but unpaid interest, without prepayment penalty provided an event of default, as defined therein, has not occurred. In the seven (7) trading days prior to any prepayment Mast Hill shall have the right to convert their Note into Common Stock of the Company in accordance with the terms of such Note. The Note contains events of defaults and certain negative covenants that are typical in the types of transactions contemplated by the Purchase Agreements. Pursuant to the Purchase Agreements, the Company issued to Mast Hill 4,960,000 commitment shares of the Company’s common stock (the “Commitment Shares”) as a condition to closing. On January 13, 2022, 549,097 shares of Restricted Common Stock were sold to five shareholders for proceeds totalling $68,000. On April 12, 2022, 125,000 shares of Restricted Common Stock were issued to five Directors serving on the Company’s Board of Directors as compensation for services to the Company. The shares were valued at the closing share price on that date, as listed on the OTC Markets, which totalled approximately $15,468. On May 26, 2022, 11,000,000 share of Restricted Common Stock were issued to the two Sellers of Mango Moi, LLC (See Note 1). The shares were valued at the closing share price on that date, as listed on the OTC Markets, which totalled approximately $550,000. During the period ended May 31, 2022, a total of 325,000 shares of Restricted Common Stock were sold to two shareholders for proceeds totalling approximately $40,248. Shares Cancellable On September 17, 2021, our Board of Directors unanimously approved to enter into and consummate a “Term Sheet” with Williamsburg Venture Holdings LLC, a Nevada limited liability company (“WVH”). WVH is a multi-strategy, private investment fund located in New York. The Term Sheet was a private placement with registration rights, providing WVH the ability to purchase up to $30,500,000 of our Common Stock. The term of the Term Sheet was for 36 months. Following the execution of the term sheet, the Company was to pay WVH $15,000 to cover associated expenses relating to, amongst other things, preparation of future securities agreements relating to the Term Sheet. Upon entering into definitive agreements with WVH for the purchase and sale of equity, WVH was to immediately purchase $250,000 of the Company’s restricted common stock from the Company at a 15% discount to the last closing price of our Common Stock as reported by the OTC Markets Group. Any future proceeds from the sale of shares, pursuant to the aforementioned term sheet, are to go towards the Company to be used for working capital. On December 2, 2021 7,048,873 shares of common stock were issued to WVH in order to honor the above agreement. However, WVH did not transfer the $250,000 purchase price of the shares to the Company and on April 12, 2022 an agreement to terminate the previous agreement was signed. On April 13, 2022 the Company forwarded a cancellation order to its transfer agent, which authorized the cancellation and return of 7,048,873 common shares previously issued to WVH. As of the date of filing, these shares have been cancelled and returned to the Company. Stock Options During the fiscal year ended February 28, 2022, the Company granted options exercisable for up to 20,000,000 shares of Common Stock of which 6,500,000 fully vested on May 31, 2022. The remaining 13,500,000 shares vest over the next 2 years. During the three months ended May 31, 2023, no shares were forfeited. The options have the exercise price of $.25 per share. These options expire 5 years after issue. The aggregate intrinsic value of these outstanding options as of May 31, 2022, was $0. The Company fair valued the options on the grant at $2,127,565 using a Black-Scholes option pricing model with the following assumptions: stock price of $.15 and $.11 per share (based on the quoted trading price on the dates of the grants). The Company is amortizing the expense over the vesting terms of each. The total stock option expense for the period ended May 31, 2022 was approximately $411,315. The total unamortized stock option expense at May 31, 2022 was approximately $2,151,622. Additional Paid-In Capital During the quarterly period ended May 31, 2022, a total of $2,609,749 posted as additional paid-in capital. This includes Common Shares issued for services for the Company including negative $249,295 for the termination of the Williamsburg Venture Holdings’ Equity Purchase Agreement, a negative $33 due to a clerical error, the common shares related to these Subscription Agreements were not issued until Q1 of 2022, $411,315 of share option vestment/expense for the Board of Directors, $272,226 for Mast Hill, $548,900 for purchase of Mango Moi Subsidiary/No subsidiary acquired this quarterly filing, and $78,072 in Warrants issued related to MacRab, 13,514 in Warrants related to JH Darbie finder’s agreement and debt treatment of Mast Hill, and $49,686 in debt forgiveness of accrued expense payable to Green Ohio Ventures. The Company’s former sole officer and director, Jeffrey DeNunzio, paid expenses on behalf of the company totalling $6,441 during the year ended February 28, 2022. During the year ended February 28, 2022, former related party Paul Moody paid expenses on behalf of the Company totalling $500. The Company’s former sole officer and director, Jeffrey DeNunzio, paid expenses on behalf of the company totalling $1,185 during the year ended February 28, 2021. The $8,126 in total payments made by the former directors are considered contributions to the company with no expectation of repayment and are posted as additional paid-in capital.

Related-Party Transactions

Related-Party Transactions	3 Months Ended
	May 31, 2022
Related-Party Transactions [Abstract]
Related-Party Transactions	Note 10 - Related-Party Transactions Loan to Company During the period ended May 31, 2022, Green Ohio Ventures, LLC, paid expenses on behalf of the Company totalling approximately $2,323 and the Company made payments to Green Ohio Ventures, LLC, totalling approximately $96,079, which resulted in Green Ohio Ventures being owed approximately $0 for loans made to the Company. These payments are considered as loans to the Company, which are noninterest-bearing, unsecured and payable on demand. In addition, the Company acquired $35,000 of a loan to Mango Moi, LLC when it became a wholly-owned subsidiary of the Company. This loan was made to Mango Moi, LLC by a relative of Amanda Cayemitte (i.e., Mr. Gushy Joseph), one of the sellers of the subsidiary.

Goodwill

Goodwill	3 Months Ended
	May 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Note 11 – Goodwill In the previous filing, the Company reported an Impairment Expense of $577,473. In recategorization of the Company’s financials to meet GAAP standards, the Company removed the Impairment Expense related to the Company’s purchase of Mango Moi, LLC (“Mango Moi”) as a wholly-owned subsidiary. The revised financials now reflect Goodwill in the amount of $583,586. While changes in circumstances requiring an interim goodwill impairment test have not been identified for the three months ended May 31, 2022. The Company will continue to monitor circumstances, such as disposition activity, stock price declines or changes in forecasted cash flows in future periods. If the fair value of the Company’s reporting unit declines below the carrying value in the future, goodwill impairment charges may be incurred.

Subsequent Events

Subsequent Events	3 Months Ended
	May 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 12 - Subsequent Events On June 7, 2022, Better For You Wellness, Inc. (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreements”) with Mast Hill Fund, L.P., a Delaware limited partnership (“Mast Hill”), respectively, pursuant to which Mast Hill purchased a promissory note, with a principal amount of $310,000 for a purchase price of $279,000 (the “Note”). The closing of the Purchase Agreements occurred on June 7, 2022. The Note bears an original issue discount of $31,000, each bear interest of 12% per year and mature on June 7, 2023 (the “Maturity Date”). The Note is convertible into shares of the Company’s common stock at conversion price of $0.037 per share, subject to adjustment as provided therein. The Company has the right to prepay the Note in full, including accrued but unpaid interest, without prepayment penalty provided an event of default, as defined therein, has not occurred. In the seven (7) trading days prior to any prepayment Mast Hill shall have the right to convert their Note into Common Stock of the Company in accordance with the terms of such Note. The Note contains events of defaults and certain negative covenants that are typical in the types of transactions contemplated by the Purchase Agreements. Pursuant to the Purchase Agreements, the Company issued to Mast Hill 4,960,000 commitment shares of the Company’s common stock (the “Commitment Shares”) as a condition to closing. In connection with the Purchase Agreements, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with Mast Hill, pursuant to which the Company is obligated to file a registration statement within 90 days of the date of the Registration Rights Agreement covering the sale of the Commitment Shares and the shares of the Company’s common stock that may be issued to Mast Hill pursuant to the conversion of the Note. JH Darbie & Co., Inc. (“JH Darbie”) and the Company are parties to a Finder’s Fee Agreement, signed March 15, 2020 (“Finder’s Agreement”) pursuant to which JH Darbie would introduce the Issuer to third-party investors. Pursuant to the Finder’s Agreement, fees of approximately $22,320.00 were paid to JH Darbie. In addition, JH Darbie is to receive non-callable warrants of equal to 8% warrant coverage of the amount raised. The warrants shall entitle JH Darbie thereof to purchase common stock of the Company at a purchase price equal to 120% of the exercise price of the transaction or the public market closing price of the Issuer’s common stock on the date of the Transaction, whichever is lower (such price, the “Warrant Price”). The warrants shall be exercisable immediately after the date of issuance, shall have anti-dilutive price protection, participating registration rights, and shall expire 5 years after the date of issuance, in accordance with the Finder’s Agreement. On June 18, 2022, Dr. Nicola Finley advised the Company’s board of directors that she will resign as a board member of the Company and that her resignation is effective immediately. Dr Finley also notified the board of directors of her willingness to voluntarily relinquish the compensatory options referenced in her Director Agreement dated August 29, 2021. The resignation of Dr. Finley was not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices. On June 20, 2022, the Company’s board of directors unanimously approved the appointment of Melisse Gelula as a non-executive independent director of the Company, effective immediately. On July 11, 2022, the Company entered into a Common Share Option Cancellation and Forfeiture Agreement with former Director Dr. Nicola Finley (the “Option Cancellation and Forfeiture Agreement”). Under the Option Cancellation and Forfeiture Agreement, Dr. Nicola Finley forfeited, and the Company canceled Dr. Nicola Finley’s option to purchase 4,000,000 common shares of the Company that was granted to the optionee pursuant to the Director Agreement dated as of August 29, 2021. Upon such forfeiture and cancellation, Dr. Nicola Finley has no further rights to exercise the option to purchase 4,000,000 common shares of the Company. The cancellation and forfeiture set forth in the Option Cancellation and Forfeiture Agreement shall not affect the restricted common shares granted by the Company to Dr. Nicola Finley pursuant to the Director Agreement dated as of August 29, 2021. As a payment in lieu of whatever benefits, if any, to which Dr. Nicola Finley may have been entitled to under the option to purchase 4,000,000 common shares of the Company, the Company shall pay Dr. Nicola Finley $1.00. On July 19, 2022, the Company’s Compensation Committee approved a formal Employment Agreement with Ian James, the Company’s Chief Executive Officer and the Company entered into the Agreement with Mr. James as of July 21, 2022. On July 19, 2022, the Company’s Compensation Committee approved a formal Employment Agreement with Stephen Letourneau, the Company’s Chief Branding Officer and the Company entered into the Agreement with Mr. Letourneau as of July 21, 2022.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	May 31, 2022
Organization and Description of Business [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying interim unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”), including the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in the Company’s annual consolidated financial statements on Form 10-K have been condensed or omitted. The condensed consolidated balance sheet as of February 28, 2022 has been derived from the audited consolidated financial statements as of that date, but does not include all disclosures required for audited annual financial statements. For further information, please refer to and read these interim condensed Consolidated Financial Statements in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 28, 2022 filed with the SEC.
Revenue Recognition	Revenue Recognition The Company has prepared its unaudited condensed consolidated financial statements in accordance with GAAP. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. The Company adopted ASC 606 - Revenue from contracts with Customers: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. Revenue for products is recognized when the products are delivered to the customer, and the customer completes the product inspection. Cash receipts for undelivered products are recorded as deferred revenues. As of May 31, 2022 and February 28, 2021, the Company had no deferred revenues.
Basis of Presentation	Basis of Presentation This summary of significant accounting policies is presented to assist in understanding the Company’s unaudited condensed consolidated financial statements. These accounting policies conform to accounting principles, generally accepted in the United States of America, and have been consistently applied in the preparation of the financial statements.
Use of Estimates	Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents at May 31, 2022 and February 28, 2022 was $3,309 and $9,642, respectively.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740, “ Income Taxes
Basic Earnings (Loss) Per Share	Basic Earnings (Loss) Per Share The Company computes basic and diluted earnings (loss) per share in accordance with ASC Topic 260, Earnings per Share
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. ASC 820, Fair Value Measurements and Disclosures - Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. - Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. - Level 3 - Inputs that are both significant to the fair value measurement and unobservable. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of May 31, 2022 and February 28, 2022. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accrued expenses.
Related Parties	Related Parties The Company follows ASC 850, Related Party Disclosures,
Share-Based Compensation	Share-Based Compensation ASC 718, “ Compensation - Stock Compensation The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “ Equity – Based Payments to Non-Employees.” Except as specified for the Independent Directors’ compensation, the Company had no stock-based compensation plans as of May 31, 2022 and February 28, 2022.
Property and Equipment	Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Depreciation is provided using the straight-line method over the estimated useful lives of the related assets (primarily three to five years).

Business Combinations (Tables)

Business Combinations (Tables)	3 Months Ended
	May 31, 2022
Business Combinations [Abstract]
Schedule of fair value of such assets and liabilities	Assets acquired: Cash $ 913 Inventory 12,995 Total Assets Acquired 13,908 Liabilities assumed: Clearbanc Debit Card 2,365 Notes Payable - PayPal Capital 2,454 Notes Payable Shopify Capital 537 Sales Tax Payable 138 Total Liabilities Assumed 5,494 Total identifiable net assets 8,414 Purchase price 592,000 Goodwill - Excess of purchase price over fair value of net assets acquired on acquisition date $ 583,586
Schedule of condensed consolidated results of operations	For the Three months ended (unaudited) (unaudited) May 31, May 31, Total revenues $ 6,974 $ 19,455 Net (loss) income $ (891,872 ) $ (90,902 ) Loss per share $ - $ -
Schedule of amounts of revenue and earnings of mango moi	For the For the 2022 2021 Mango Moi: Total revenues $ 6,974 $ 19,455 Net income $ (8,281 ) $ (9,425 )

Organization and Description _2

Organization and Description of Business (Details) - USD ($)		1 Months Ended
	Sep. 02, 2021	Aug. 25, 2021	Aug. 24, 2021	Jul. 30, 2021	Jul. 18, 2021	May 31, 2022	Apr. 29, 2022	Feb. 28, 2022
Organization and Description of Business (Details) [Line Items]
Independent director agreements, description	we entered into Independent Director Agreements with each of Montel Williams, Leslie G. Bumgarner, Joseph J. Watson, David H. Deming, and Dr. Nicola R. Finley, MD, pursuant to which each director will serve two year terms, with the option to renew terms upon completion, and receive cash compensation in the amount of $1,000 per annum, paid in equal $250 distributions quarterly, and 200,000 shares of common stock, issued quarterly in 25,000 share distributions, and a non-qualified stock option to purchase up to 4,000,000 shares of the Company’s common stock at an exercise price of $0.25 per share.
Common stock, par value (in Dollars per share)						$ 0.0001		$ 0.0001
Shares of common stock						500,000,000		500,000,000
Fair market value (in Dollars)							$ 550,000
Common stock, shares issued						380,108,169		370,747,042
Fast Track Solutions, Inc. [Member]
Organization and Description of Business (Details) [Line Items]
Shares of common stock						1,000
Series A Preferred Stock [Member]
Organization and Description of Business (Details) [Line Items]
Shares of restricted common stock					250,000,000
Series of Individually Immaterial Business Acquisitions [Member]
Organization and Description of Business (Details) [Line Items]
Owning, percentage		5%
Purchase Price [Member]
Organization and Description of Business (Details) [Line Items]
Voting percentage				89.62%
Paid consideration (in Dollars)				$ 335,000
Predecessor [Member]
Organization and Description of Business (Details) [Line Items]
Shares of common stock						1,000
CRS Consulting, LLC [Member] | Common Stock [Member]
Organization and Description of Business (Details) [Line Items]
Shares of common stock				250,000,000
CRS Consulting, LLC [Member] | Series A Preferred Stock [Member]
Organization and Description of Business (Details) [Line Items]
Shareholder owning preferred stock					700,000
Sale of shares				700,000
CRS Consulting, LLC [Member] | Series of Individually Immaterial Business Acquisitions [Member]
Organization and Description of Business (Details) [Line Items]
Voting percentage				89.62%
Ian James [Member] | Series A Preferred Stock [Member]
Organization and Description of Business (Details) [Line Items]
Transfer of shares				350,000
Stephen Letourneau [Member] | Series A Preferred Stock [Member]
Organization and Description of Business (Details) [Line Items]
Transfer of shares				350,000
Green Ohio Ventures, LLC [Member]
Organization and Description of Business (Details) [Line Items]
Shares of common stock				250,000,000
MRKTS Group Inc [Member]
Organization and Description of Business (Details) [Line Items]
Shares of restricted common stock			17,963,817
MRKTS Group Inc [Member] | Purchase Price [Member]
Organization and Description of Business (Details) [Line Items]
Owning, percentage			5%
Better for You Wellness, Inc. [Member]
Organization and Description of Business (Details) [Line Items]
Shares of restricted common stock		24,137,499
Mango Moi, LLC [Member] | Common Stock [Member]
Organization and Description of Business (Details) [Line Items]
Common stock, par value (in Dollars per share)							$ 0.0001
Shares of common stock							11,000,000
Amanda Cayemitte [Member] | Common Stock [Member]
Organization and Description of Business (Details) [Line Items]
Common stock, shares issued							5,720,000
Yapo M’be [Member] | Common Stock [Member]
Organization and Description of Business (Details) [Line Items]
Common stock, shares issued							5,280,000

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended
	May 31, 2022	Feb. 28, 2022
Organization and Description of Business [Abstract]
Significant Accounting Policies and Use of Estimates	Significant Accounting Policies and Use of Estimates: There were no material changes in the Company’s significant accounting policies for the three months ended May 31, 2022 as compared to the year ended February 28, 2022. See Note 2 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended February 28, 2022, as filed with the SEC, for additional information regarding the Company’s significant accounting policies and use of estimates. The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ significantly from those estimates. The most significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates the valuation allowance associated with the Company’s deferred tax assets.
Cash and cash equivalents	$ 3,309	$ 9,642
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13 “Credit Losses - Measurement of Credit Losses on Financial Instruments.” ASU No. 2016-13 significantly changes how entities will measure credit losses for most financial assets, including accounts and notes receivables, by replacing today’s “incurred loss” approach with an “expected loss” model under which allowances will be recognized based on expected rather than incurred losses. ASU No. 2016-13 will become effective for us in the first quarter of 2023. We are evaluating the impact that the adoption of this update will have on our financial statements; however, it is not expected to be material.
Reclassification of Prior Year Presentation	Reclassification of Prior Year Presentation Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

Business Combinations (Details)

Business Combinations (Details)	3 Months Ended
	May 31, 2022 USD ($)
Business Combinations [Abstract]
Purchase price of stock	$ 592,000
Goodwill	$ 583,586

Business Combinations (Detail_2

Business Combinations (Details) - Schedule of fair value of such assets and liabilities	May 31, 2022 USD ($)
Schedule Of Fair Value Of Such Assets And Liabilities Abstract
Cash	$ 913
Inventory	12,995
Total Assets Acquired	13,908
Clearbanc Debit Card	2,365
Notes Payable - PayPal Capital	2,454
Notes Payable Shopify Capital	537
Sales Tax Payable	138
Total Liabilities Assumed	5,494
Total identifiable net assets	8,414
Purchase price	592,000
Goodwill - Excess of purchase price over fair value of net assets acquired on acquisition date	$ 583,586

Business Combinations (Detail_3

Business Combinations (Details) - Schedule of condensed consolidated results of operations - USD ($)	3 Months Ended
	May 31, 2022	May 31, 2021
Schedule Of Condensed Consolidated Results Of Operations Abstract
Total revenues	$ 6,974	$ 19,455
Net (loss) income	$ (891,872)	$ (90,902)
Loss per share (in Dollars per share)

Business Combinations (Detail_4

Business Combinations (Details) - Schedule of amounts of revenue and earnings of mango moi - USD ($)	3 Months Ended
	May 31, 2022	May 31, 2021
Schedule Of Amounts Of Revenue And Earnings Of Mango Moi Abstract
Total revenues	$ 6,974	$ 19,455
Net income	$ (8,281)	$ (9,425)

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)		1 Months Ended	3 Months Ended
	Sep. 17, 2021	Sep. 17, 2021	May 31, 2022
Commitments and Contingencies (Details) [Line Items]
Common stock purchase warrant for purchase	$ 30,500,000
Associated expenses	15,000
Immediately purchase	$ 250,000
Restricted common stock discount percentage	15%
Outstanding shares percentage	4.99%
Amount paid			$ 22,320
Annual salary of payable			$ 65,000
Consulting agreement, description			Pursuant to the Consulting Agreement, the Company engaged Yapo M’be as a consultant to provide manufacturing services for Mango Moi, to begin on May 2, 2022. As compensation under the Consulting Agreement, the Company agreed to pay Yapo M’be at the rate of $30.00 per hour, not to exceed $1,500 per month.
SRAX [Member]
Commitments and Contingencies (Details) [Line Items]
Amount paid		$ 20,000

Convertible Note Payable (Detai

Convertible Note Payable (Details)	Apr. 12, 2022 USD ($)	Apr. 12, 2022 USD ($) $ / shares shares
Convertible Note Payable (Details) [Line Items]
Principal amount	$ 310,000
Purchase price	279,000	$ 279,000
Discount amount	$ 31,000	$ 31,000
Interest rate		12%
Maturity date	Apr. 12, 2023	Apr. 12, 2023
Common stock conversion price per share (in Dollars per share) | $ / shares		$ 0.037
Mast Hill Fund, L.P., [Member]
Convertible Note Payable (Details) [Line Items]
Principal amount		$ 310,000
Purchase price	$ 279,000	$ 279,000
Commitment shares (in Shares) | shares		4,960,000

Stock Purchase Warrant Liabil_2

Stock Purchase Warrant Liability (Details)	1 Months Ended
	Apr. 18, 2022
Stock Purchase Warrant Liability [Abstract]
Stock purchase warrant liability description	Better For You Wellness, Inc., a Nevada corporation (the “Company”), entered into a Standby Equity Commitment Agreement, dated April 11, 2022 (the “SECA”) with MacRab LLC, a Florida limited liability company (the “Investor”). The SECA provides the Company with an option to sell up to $5,000,000 worth of the Company’s common stock, par value $0.0001 (the “Common Stock”), to the Investor, in increments, over the period ending twenty-four (24) months after the date the Registration Statement (as defined below) is deemed effective by the U.S. Securities and Exchange Commission, pursuant to the terms and conditions contained in the SECA. The purchase price per share, for each respective put under the SECA, is equal to 90% of the average of the two (2) lowest volume weighted average prices of the Common Stock during the six (6) trading days following the clearing date associated with the respective put under the SECA. Additionally, we issued a common stock purchase warrant for the purchase of 1,785,714 shares of our common stock (the “Warrant”) to Investor as a commitment fee in connection with the execution of the SECA. The Company fair valued the shares purchase warrant on the closing date at $36,366 using a Black-Scholes put option pricing model.

Shareholder Equity (Details)

Shareholder Equity (Details) - USD ($)

1 Months Ended

3 Months Ended

12 Months Ended

Apr. 13, 2022

Apr. 12, 2022

Jan. 13, 2022

Jan. 03, 2022

Oct. 11, 2021

Sep. 17, 2021

Aug. 25, 2021

May 26, 2022

Nov. 17, 2021

Sep. 30, 2021

Aug. 24, 2021

Jul. 19, 2021

May 31, 2022

May 31, 2021

Feb. 28, 2022

Feb. 28, 2021

Dec. 02, 2021

Nov. 30, 2021

Shareholder Equity (Details) [Line Items]

Preferred stock, shares authorized

200,000,000

200,000,000

Preferred stock, par value (in Dollars per share)

$ 0.0001

$ 0.0001

Preferred stock, shares issued

700,000

700,000

Preferred stock, shares outstanding

700,000

700,000

Preferred stock, voting rights

Series A Preferred Stock has no conversion rights to any other class, and every vote of Series A Preferred Stock has voting rights equal to 1,000 votes of Common Stock.

Common stock, shares authorized

500,000,000

500,000,000

Common stock, par value (in Dollars per share)

$ 0.0001

$ 0.0001

Common stock, shares issued

380,108,169

370,747,042

Common stock, shares outstanding

380,108,169

370,747,042

Principal amount (in Dollars)

$ 310,000

Purchase price (in Dollars)

279,000

Discount amount (in Dollars)

$ 31,000

Bears interest rate

12%

Conversion price (in Dollars per share)

$ 0.037

Commitment shares

4,960,000

Common stock value (in Dollars)

$ 30,500,000

Cover expenses (in Dollars)

$ 15,000

Common stock closing price, percentage

15%

Grant option exercisable

20,000,000

Number of vested shares

6,500,000

Stock option, description

13,500,000 shares vest over the next 2 years.

Exercise price per shares (in Dollars per share)

$ 25

Stock option expire term

5 years

Stock option outstanding intrinsic value (in Dollars)

$ 0

Stock price description

stock price of $.15 and $.11 per share (based on the quoted trading price on the dates of the grants).

Stock options fair value the grant date (in Dollars per share)

$ 2,127,565

The total stock option expense (in Dollars)

$ 411,315

Total unamortized stock option expense (in Dollars)

2,151,622

Additional paid-in capita (in Dollars)

$ 2,609,749

$ 1,485,364

Equity purchase agreement, description

This includes Common Shares issued for services for the Company including negative $249,295 for the termination of the Williamsburg Venture Holdings’ Equity Purchase Agreement, a negative $33 due to a clerical error, the common shares related to these Subscription Agreements were not issued until Q1 of 2022, $411,315 of share option vestment/expense for the Board of Directors, $272,226 for Mast Hill, $548,900 for purchase of Mango Moi Subsidiary/No subsidiary acquired this quarterly filing, and $78,072 in Warrants issued related to MacRab, 13,514 in Warrants related to JH Darbie finder’s agreement and debt treatment of Mast Hill, and $49,686 in debt forgiveness of accrued expense payable to Green Ohio Ventures.

Paid expenses (in Dollars)

Total payments considered contributions (in Dollars)

$ 8,126

Series A Preferred Stock [Member]

Shareholder Equity (Details) [Line Items]

Preferred stock, shares issued

350,000

Series A preferred stock were issued

700,000

Shares of restricted common stock

250,000,000

Board of Directors [Member]

Shareholder Equity (Details) [Line Items]

Restricted common stock

125,000

125,000

125,000

Closing share price (in Dollars)

$ 15,468

$ 15,000

$ 18,750

Jeffrey DeNunzio [Member]

Shareholder Equity (Details) [Line Items]

Paid expenses (in Dollars)

6,441

$ 1,185

CRS Consulting, LLC [Member]

Shareholder Equity (Details) [Line Items]

Restricted common stock

250,000

50,000

Closing share price (in Dollars)

$ 45,000

$ 7,000

CRS Consulting, LLC [Member] | Series A Preferred Stock [Member]

Shareholder Equity (Details) [Line Items]

Series A preferred stock were issued

700,000

Sauer Energy, Inc. [Member]

Shareholder Equity (Details) [Line Items]

Common shares, outstanding

359,996,332

Green Ohio Ventures, LLC [Member]

Shareholder Equity (Details) [Line Items]

Restricted common stock

24,137,499

17,963,817

250,000,000

SRAX, Inc [Member]

Shareholder Equity (Details) [Line Items]

Restricted common stock

2,602,740

Closing share price (in Dollars)

$ 468,493

Shareholders [Member]

Shareholder Equity (Details) [Line Items]

Restricted common stock

549,097

325,000

Proceeds total (in Dollars)

$ 68,000

$ 40,248

Mango Moi, LLC [Member]

Shareholder Equity (Details) [Line Items]

Restricted common stock

11,000,000

Closing share price (in Dollars)

$ 550,000

Williamsburg Venture Holdings LLC [Member]

Shareholder Equity (Details) [Line Items]

Common stock, shares issued

7,048,873

Purchase price of shares (in Dollars)

$ 250,000

Cancellation and return of common shares

7,048,873

Paul Moody [Member]

Shareholder Equity (Details) [Line Items]

Paid expenses (in Dollars)

$ 500

Related-Party Transactions (Det

Related-Party Transactions (Details)	3 Months Ended
	May 31, 2022 USD ($)
Related-Party Transactions (Details) [Line Items]
Loan Amount	$ 0
Ian James [Member]
Related-Party Transactions (Details) [Line Items]
Paid expenses	2,323
Green Ohio Ventures, LLC [Member]
Related-Party Transactions (Details) [Line Items]
Paid expenses	96,079
Mango Moi, LLC [Member]
Related-Party Transactions (Details) [Line Items]
Paid expenses	$ 35,000

Goodwill (Details)

Goodwill (Details)	3 Months Ended
	May 31, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill impairment expense	$ 577,473
Goodwill	$ 583,586

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)		3 Months Ended
	Jun. 07, 2022	May 31, 2022	Jul. 11, 2022	Apr. 12, 2022
Subsequent Events (Details) [Line Items]
Original issue discount				$ 31,000
Maturity date		Jun. 07, 2023
Commitment shares (in Shares)		4,960,000
Purchase agreement description		In connection with the Purchase Agreements, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with Mast Hill, pursuant to which the Company is obligated to file a registration statement within 90 days of the date of the Registration Rights Agreement covering the sale of the Commitment Shares and the shares of the Company’s common stock that may be issued to Mast Hill pursuant to the conversion of the Note.
Agreement fees		$ 22,320
Warrant coverage raised percentage		8%
Exercise price percentage		120%
Registration rights expires		5 years
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Principal amount			$ 1
Purchase price	$ 279,000
Original issue discount	$ 31,000
Interest rate	12%
Conversion price per share (in Dollars per share)	$ 0.037
Dr. Nicola Finley [Member]
Subsequent Events (Details) [Line Items]
Purchase common shares (in Shares)		4,000,000
Securities Purchase Agreement [Member] | Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Principal amount	$ 310,000
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Common stock value (in Shares)			4,000,000